A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
Brief description of study
The main goal of this study is to determine if limited surgery or high dose precision radiation is better in patients who are at an elevated risk for surgical complications with early stage lung cancer.
Clinical Study Identifier: s16-02247
ClinicalTrials.gov Identifier: NCT02468024
Principal Investigator:
Benjamin Cooper.
Other Investigators:
Kamini Barat,
Peter B. Schiff,
Virginia M Ferreira,
Robert J. Cerfolio,
Harvey I Pass.
If you are registered as a volunteer, please login to the dashboard to send referrals.